Top Markets
Coin of the day
Cognetivity Neurosciences Ltd. Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd.

CGN
Rank in Stocks #39084
Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in... Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in the development of an integrated cognitive assessment platform. This advanced testing system, applicable across medical, commercial, and consumer environments, is designed to identify the earliest indicators of cognitive impairment by evaluating the performance of broad brain regions, thereby aiding in the diagnosis of dementia. The company also offers OptiMind, a dedicated wellness application. Established in 2015, Cognetivity Neurosciences Ltd. maintains its headquarters in Vancouver, Canada. The organization was previously known as Utor Capital Corp. before adopting its current name in December 2017.
Share Price
$0.00733937
Last synced: 2024-07-23
Market Cap
$657.52K
Change (1 day)
0.51%
Change (1 year)
0.00%
Country
CA
Trade Cognetivity Neurosciences Ltd. (CGN)

Category

P/B ratio for Cognetivity Neurosciences Ltd. (CGN)
P/B ratio as of 2026 TTM: 0
According to Cognetivity Neurosciences Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Cognetivity Neurosciences Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors